1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
USAMRDC/Defense Health Agency Broad Agency Announcement for Extramural Medical Research is sponsored by U.S. Army Medical Research and Development Command (USAMRDC) / Defense Health Agency (DHA). This continuously open Broad Agency Announcement (BAA) funds extramural medical research in areas relevant to military health, including combat casualty care, TBI, and psychological health.
Get alerted about grants like this
Get emailed when new opportunities from “U.S. Army Medical Research and Development Command (USAMRDC) / Defense Health Agency (DHA)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Agency: Defense Health Agency Contracting Activity - DHACA Assistance Listings: 12.
420 -- Military Medical Research and Development Last Updated: May 13, 2026 View version history on Grants. gov The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large.
The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC.
General information on the USAMRDC can be obtained at https://mrdc. health. mil/.
This BAA is intended to solicit extramural research and development ideas using the authority provided by 10 USC 4001. The BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in FAR 6. 102(d)(2) and 35.
016 and in Department of Defense Grant and Agreement Regulations (DoDGARs) 22. 315. In accordance with FAR 35.
016, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Research and development funded through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA utilizes competitive procedures in accordance with 10 USC 3012 for the selection for award of S&T proposals/applications.
For the purposes of this BAA, S&T includes activities involving basic research, applied research, advanced technology development, and, under certain conditions, may include activities involving advanced component development and prototypes.
The selection process is highly competitive, and the quantity of meaningful submissions (both pre-proposals/pre-applications and full proposals/applications) received typically exceeds the number of awards that available funding can support.
This BAA provides a general description of USAMRDC’s research and development programs, including Research Areas of Interest, evaluation and selection criteria, pre-proposal/ pre-application and full proposal/application preparation instructions, and general administrative information.
Specific submission information and additional administrative requirements can be found in the document titled, “General Submission Instructions,” which is available on Grants. gov along with this BAA. The FY23-FY27 USAMRDC BAA is continuously open for a 5-year period, from October 1, 2022 through September 30, 2027, at 11:59 p.
m. Eastern Time. Submission of a pre-proposal/pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.
org/). Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period. If the USAMRDC is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP.
A full proposal/application must be submitted through Grants. gov (http://www. grants.
gov/). Invited full proposals/applications can be submitted under this FY23-FY27 BAA through September 30, 2027. Grantor contact information File name Description Last updated HT942523SBAA1_27Jan2026.
pdf FY25 MRDC BAA HT942523SBAA1 Link to additional information Closing: September 30, 2027 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Science technology and other research and development Your account requires additional identity verification.
According to the current listing, eligibility includes: All qualified and responsible prime applicants located in the United States are eligible to submit proposals. Confirm the full requirements in the official notice before applying.
Applications for USAMRDC/Defense Health Agency Broad Agency Announcement for Extramural Medical Research are due September 1, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
USAMRDC/Defense Health Agency Broad Agency Announcement for Extramural Medical Research is funded by U.S. Army Medical Research and Development Command (USAMRDC) / Defense Health Agency (DHA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
DARPA transferred its first autonomous-ready H-60Mx Black Hawk to the Army on March 20, capping a decade of ALIAS research. Now the same technology underpins an SBIR XL opportunity for small businesses building wildfire autonomy.
Read articleThe Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleAfter SBIR reauthorization, the U.S. Army released five new small-business topics under Army FUZE — Ka-Band metamaterial radar, a Li-ion 6T battery open topic, in-transit-visibility blockchain, modular UAS payloads, and the xTech|Phantum prize competition. Awards run from $150K to $300K per Phase I. But the bigger story is the Army's shift from funding parts to funding whole systems. Here is what each topic funds and how to compete.
Read article